What's in Medtronic - MITG's pipeline?

Medtronic - MITG has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Medtronic - MITG's portfolio?

Top competitors by shared drug class: Camlıca Erdem Hospital, St. Joseph's Healthcare Hamilton.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/medtronic-mitg.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Medtronic - MITG — Portfolio Competitive Intelligence Brief

Medtronic - MITG pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Senna tablets	Senna tablets	marketed	Stimulant laxative	Colonic smooth muscle and intestinal epithelium	Gastroenterology

Therapeutic area mix

Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Camlıca Erdem Hospital · 1 shared drug class
St. Joseph's Healthcare Hamilton · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Medtronic - MITG:

Cite this brief

Drug Landscape (2026). Medtronic - MITG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/medtronic-mitg. Accessed 2026-05-16.